leisure time -WSS

leisure time

author：focus 2025-09-28 05:04:36 - browse：12365

JOSEPH PREZIOSO/AFP via Getty Images

LONDON — The U.K.’s cost-effectiveness watchdog said Thursday it is not yet recommending Vertex’s CRISPR-based therapy for sickle cell disease, saying in draft guidance it has questions about the medicine’s lasting benefits for patients.

U.K. regulators approved the therapy, known as Casgevy or exa-cel, last year, granting it the world’s first authorization for any CRISPR-based medicine. But observers have been watching to see how the U.K.’s National Institute for Health and Care Excellence, as well as similar agencies in European countries, would view the pricey, one-time therapy. NICE needs to recommend the therapy for it to be offered in the National Health Service.

In the U.S., Casgevy has a list price of $2.2 million. It was developed by Vertex in partnership with CRISPR Therapeutics.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： 23andMe had bad news about my health. I wish a person had delivered it
Next article： Why Sanofi got shellacked over its spinoff

Wikipedia

WSS

Why Sanofi got shellacked over its spinoff

Trump allegedly attempted to have surveillance video deleted: Special Counsel

VC firm RA Capital starts a new synthetic biology incubator

An outrageous hospital charge: I paid $710 for an hour of babysitting

The FDA weighs the risks of candy

Timeline: Special counsel's probe into Trump's handling of classified documents

leisure time

leisure time

explore

Hollywood unions extend contract negotiations for actors

VC firm RA Capital starts a new synthetic biology incubator

What does generative AI mean for health care? We asked experts

Timeline: Special counsel's probe into Trump's handling of classified documents

What does generative AI mean for health care? We asked experts

Hospitals, health systems can help patients avoid medical debt

Wildfire smoke exposes gaps in outdoor worker protections

Telehealth options flood the market as retailers push virtual care

Jerome Adams on the need for new antivirals for Covid

Public health communication lessons from Covid

hotspot

Ending health disparities requires full federal government, panel says

An outrageous hospital charge: I paid $710 for an hour of babysitting

Why Sanofi got shellacked over its spinoff

The mammogram wars are not over

WHO may add ‘noma' to its list of neglected tropical diseases

Biden to sign 'historic' executive order on how US military handles sexual assault cases

Wikipedia

focus

focus

hotspot